Abacavir is a potent selective inhibitor of HIV-1 and HIV-2. The mechanism of action as to HIV, is the inhibition of the enzyme reverse transcriptase of HIV, an event that causes chain termination and stopping the replication cycle of the virus.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
$substanceName is the active ingredient of these drugs:
South Africa
South Africa
South Africa
Ecuador
South Africa
South Africa
South Africa
South Africa
South Africa
Australia Austria Canada Cyprus Estonia
Brazil
$substanceName is also found within below combination drugs:
ABAVILAM , AZADAR , BACATAC , COABLAM , DUMIVA , EPZICOM , HETERUAM , KIVALA , KIVEXA , MYLAMBA , PROFELVIR , QUADRIMUNE , QULAM-CO , RETRIKIL , TERZALA , TRELAVUE , TRIUMEQ , TRIZIVAR , TRIZIVIR , VIROXIAL , VIRULATE , VUBIR , VUDIMAX
Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):